Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -144,735 | -301,743 | 49,271 | -198,375 | -87,931 |
| Depreciation Amortization | -5,001 | -8,952 | -8,852 | -1,569 | 173 |
| Accounts receivable | 359 | 39,602 | -24,744 | -15,306 | N/A |
| Accounts payable and accrued liabilities | 580 | -19,102 | 15,882 | 1,854 | 670 |
| Other Working Capital | -1,083 | -45,831 | -65,661 | -1,641 | 4,595 |
| Other Operating Activity | 26,537 | 168,379 | 46,023 | 35,166 | 7,694 |
| Operating Cash Flow | $-123,343 | $-167,647 | $11,919 | $-179,871 | $-74,799 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,177 | 112,014 | 93,294 | -236,462 | -46,053 |
| PPE Investments | -138 | -36,360 | -1,241 | -2,526 | -353 |
| Investing Cash Flow | $14,039 | $75,654 | $92,053 | $-238,988 | $-46,406 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 26,159 |
| Debt Repayment | N/A | N/A | N/A | N/A | -263 |
| Common Stock Issued | 4,077 | 2,132 | 6,858 | 434,636 | 343 |
| Other Financing Activity | 252,952 | -1,784 | -3,315 | -2,847 | 132,267 |
| Financing Cash Flow | $257,029 | $348 | $3,543 | $431,789 | $158,506 |
| Exchange Rate Effect | 1,074 | -438 | 160 | -65 | 13 |
| Beginning Cash Position | 78,837 | 170,920 | 63,245 | 50,380 | 13,066 |
| End Cash Position | 227,636 | 78,837 | 170,920 | 63,245 | 50,380 |
| Net Cash Flow | $148,799 | $-92,083 | $107,675 | $12,865 | $37,314 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,343 | -167,647 | 11,919 | -179,871 | -74,799 |
| Capital Expenditure | -138 | -36,360 | -1,241 | -2,526 | -353 |
| Free Cash Flow | -123,481 | -204,007 | 10,678 | -182,397 | -75,152 |